Magda Michna - 12 Mar 2026 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role
Chief Development Officer
Signature
/s/ Magda Michna
Issuer symbol
STAA
Transactions as of
12 Mar 2026
Net transactions value
$0
Form type
4
Filing time
16 Mar 2026, 17:00:14 UTC
Previous filing
14 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Michna Magda Chief Development Officer 25510 COMMERCENTRE DRIVE, LAKE FOREST /s/ Magda Michna 16 Mar 2026 0001731487

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STAA Common Stock Options Exercise +6,178 +43% $0.000000* 20,622 12 Mar 2026 Direct F1
transaction STAA Common Stock Tax liability -2,216 -11% $18.39* 18,406 12 Mar 2026 Direct F1
transaction STAA Common Stock Options Exercise +14,663 +80% $0.000000* 33,069 14 Mar 2026 Direct F3
transaction STAA Common Stock Options Exercise +2,932 +8.9% $0.000000* 36,001 14 Mar 2026 Direct F4
transaction STAA Common Stock Tax liability -6,313 -18% $18.84* 29,668 14 Mar 2026 Direct F3, F4, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STAA Restricted Stock Units Options Exercise -6,178 -50% $0.000000* 6,178 12 Mar 2026 Common Stock 6,178 $0.000000 Direct F1, F6
transaction STAA Restricted Stock Units Award +33,838 $0.000000* 33,838 13 Mar 2026 Common Stock 33,838 $0.000000 Direct F2, F6
transaction STAA Restricted Stock Units Options Exercise -14,663 -33% $0.000000* 29,326 14 Mar 2026 Common Stock 14,663 $0.000000 Direct F3, F6
transaction STAA Restricted Stock Units Options Exercise -2,932 -33% $0.000000* 5,866 14 Mar 2026 Common Stock 2,932 $0.000000 Direct F4, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (6,177 shares) on March 12, 2025, 1/3 (6,178 shares) on March 12, 2026, and will vest as to 1/3 (6,178 shares) on March 12, 2027. On March 12, 2026, 2,216 shares were witheld upon vesting to satisfy taxes.
F2 Reflects RSUs granted to the Reporting Person on March 13, 2026 in connection with annual equity award. These RSUs vest as to 1/3 (11,279 shares) on March 13, 2027, 1/3 (11,279 shares) on March 13, 2028, and 1/3 (11,280 shares) on March 13, 2029.
F3 Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (14,663 shares) on March 14, 2026, and will vest as to 1/3 (14,663 shares) on March 14, 2027, and 1/3 (14,663 shares) on March 14, 2028. On March 14, 2026, 5,261 shares were witheld upon vesting to satisfy taxes.
F4 Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (2,932 shares) on March 14, 2026, and will vest as to 1/3 (2,933 shares) on March 14, 2027, and 1/3 (2,933 shares) on March 14, 2028. On March 14, 2026, 1,052 shares were witheld upon vesting to satisfy taxes.
F5 Includes previously granted RSUs, which are subject to future vesting.
F6 Each RSU represents the right to receive one share of the Corporation's common stock upon vesting.